Search
Patexia Interest Groups

Medical Regulation > Nova Content

If you are one of the 48 percent of Americans that took a prescription drug in the past month, you probably read through a litany of potential side effects attributed ... Read More »
If you are one of the 48 percent of Americans that took a prescription drug in the past month, you probably read through a litany of potential side effects attributed ... Read More »
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life ... Read More »
Here’s the weekly collection of hot medical news! Health on trial at the Supreme Court The Supreme Court has been busy with health topics. First... Read More »
An unprecedented three days of oral arguments before the US Supreme Court debating the constitutionality of key aspects of President Obama’s Affordable Care Act ... Read More »
Many experts would agree that healthcare in the United States suffers from a degree of incoordination and fragmentation.  Estimates suggest that two out of three ... Read More »
Amid concerns about possible terrorist attacks with nuclear materials, and fresh memories of environmental contamination from the 2011 Fukushima Daiichi nuclear... Read More »
Pink slime fed to kids at schools. Listeria and arsenic found in food. Even food packaging can leech unhealthy chemicals into our diet. While the cases of severe ... Read More »
Most of us have turned to the Internet when we’ve felt under the weather at one point or another. We Google our symptoms to self-diagnose and sometimes we even... Read More »
We’re all familiar with the so-called weight loss drugs advertised on TV that claim unbelievable results, show before and after shots of what are clearly... Read More »
There has been an explosion of news suggesting a bioethical scandal in recent days. A quick Google search for “CellTex scandal” will produce over 7,000... Read More »
Comments
Rich VNatural Embryonic or adult stem cells are not a drug and cannot be patented, but once they are manipulated they can be patented and sold. Big bucks for the companies and more power to a very corrupt FDA.
There are people on their deathbed that would be willing to take a chance with embryonic cells but the government can’t let that happen because if it works those patented stem cells would be worth nothing. It’s all about the money, and that’s it.
I know of a patient that was killed the night before he was to be transferred to a university hospital back in 2005 to have the procedure done – Of course the report said natural circumstances.
It’s bad enough that the lawyers are crooks but now the FDA and some doctors have become murderers.
Aug 7, 2012
Here's your weekly summary of the top medical news of the week! CellTex scandal breakdown: Stem cells, Rick Perry and the FDA There has been an explosion... Read More »
New technology could significantly decrease the cost of drug discovery, potentially leading to increased access to high-quality, personalized health care. Steven... Read More »
In the late 1990s, Novartis manufactured and patented imatinib (with the brand name Gleevec), a drug that prolongs life in patients with chronic myelogenous leukemia... Read More »
Competing medical device manufacturers are racing to get an artificial pancreas to the market.  The FDA has yet to approve specific artificial pancreas... Read More »
For medical uses, the only FDA-approved radio frequency identification (RFID) chip is the one made by VeriChip Corp, a division of Applied Digital Solutions... Read More »
Air Products is launching an innovative gas cylinder with built-in barrier technology to drive hygiene and safety standards in the food packaging... Read More »
New chemical analyses have found that Coca-Cola, Pepsi, Diet Coke, and Diet Pepsi contain high levels of 4-methylimidazole (4-MI), a known animal carcinogen. The... Read More »
Agilent Technologies today introduced Agilent SureFISH probes, their next generation of fluorescent in situ hybridization (FISH) assays, delivering a comprehensive... Read More »
Cases in which a newly approved drug is more effective than the cheaper alternatives already available are the exceptions rather than the rule. This is the conclusion ... Read More »
Menu